Engineering next-generation precision therapies to treat a debilitating disease in children
Florey researchers are working on precision medicines to treat ataxia-telangiectasia (A-T), a debilitating childhood disease.
Read time: 3 mins
View more
Florey researchers are working on precision medicines to treat ataxia-telangiectasia (A-T), a debilitating childhood disease.
Read time: 3 mins
View more
Your source of neuroscience and mental health insights from The Florey. Learn about the latest the latest discovery into the role of inflammation in multiple sclerosis; meet 3 researchers representing and empowering change for women's health outcomes and care; and find out about our latest community events, where we showcase the important work being undertaken at The Florey.
ReadKey points Epilepsy is the most common serious brain disorder globally. One in 25 Australians will be diagnosed with epilepsy at some stage in their lives. The Australian Epilepsy Project (AEP) is setting a new standard of care that simplifies the journey from diagnosis to treatment. Will Campbell was referred to the AEP where a small structural abnormality in his brain that was driving his…
Read time: 4 mins
View more
The Florey welcomes Professor Shelley Dolan and Jodie Geissler to its Board of Directors, and farewells Professor Christine Kilpatrick AO from the Board.
Read time: 2 mins
View more
The Australian Stroke Clinical Registry (AuSCR), led by The Florey, was established to monitor stroke care across hospitals in Australia to improve patients' quality of life.
Read time: 3 mins
View more
Research Officer
Dr Ellett works in neurodegeneration research, focusing on prion disease. She has a background in nutrition, protein biochemistry and microbiology.
View more
This study will establish whether targeting interneurons in the motor region of the brain is a potential therapeutic target for motor neurone disease.
Learn moreMs Jodie Geissler joined The Florey Board of Directors in May 2025, and is Chief Executive Officer of Austin Health.
View more
Professor Shelley Dolan joined The Florey Board of Directors in May 2025. She is Chief Executive at the Royal Melbourne Hospital.
View more
PhD student Montanna Waters' experience caring for Jaeli and Dali Williams, who live with SYNGAP1, inspired her to pursue epilepsy research at The Florey.
Read time: 4 mins
View more